Right, I understand that estimate versus the risk estimate (as they applied those success percentages to scale the revenue figures) but I guess what I am asking is why are they providing two different estimates? We all know that market value because we can look at the ticker, so I thought the point of providing an estimated value was to use the anticipated future revenues of the current pipeline and give the estimate of the what the company SHOULD be valued. Therefore, the report should be saying the market is undervaluing CTIX and MP Advisors is advocating an upside of $428M in company valuation right now. I guess I just don't understand why they would provide the two different estimates.
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links